This Was a Cause Before It Was a Company
We believe in a world where patient care is no longer pre-determined by the limitations of current tools. We create platforms that enhance physician capabilities, evolve minimally invasive techniques, and create new categories of care that redefine optimal patient outcomes.
This is our mission.
Over the past 50 years, the introduction of new technologies has ushered in the era of minimally invasive techniques and procedures. Despite accessing the body in less invasive ways, all too often physicians are required to sacrifice healthy tissue, perform multiple interventions, and endure numerous tradeoffs while diagnosing and treating disease.
With the Monarch Platform, Auris will empower physicians with precision and consistency of care across medical intervention. The Monarch Platform improves upon existing minimally invasive techniques by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform to enable new categories of care. Every element of our technology is driven by patient-centric design aimed at maintaining the integrity of the human body.
Auris Health is led by Dr. Frederic Moll, a physician and visionary entrepreneur with an unrelenting passion and drive for improving patient outcomes. Dr. Moll pioneered the field of surgical robotics starting his first robotics company in 1995. Under Dr. Moll’s leadership, Auris is committed to tackling some of the biggest problems in healthcare. We are developing solutions for a multitude of disease states where the standard treatments may be inconsistent and sub-optimal.
Lung cancer is the first disease in our sight. More patients die every year from lung cancer than from prostate, breast and colon cancer combined. Lung cancer is so deadly because it is usually diagnosed late and treatment can be ineffective. Auris designed the Monarch Platform to allow physicians to accurately access small and hard-to-reach lung nodules early, for diagnosing and targeting treatment.
At Auris, the future of medical intervention has arrived.
Fred Moll, M.D. is the co-founder and CEO of Auris. Prior to Auris, Dr. Moll was a founder of three public companies; Hansen Medical (HNSN) Restoration Robotics (HAIR) and Intuitive Surgical (ISRG). Prior to Intuitive, he served as a founder and medical director of Origin Medsystems, acquired by Eli Lily, and Endotherapeutics, acquired by United States Surgical.
Josh has been working with Auris since 2015. He has more than 15 years of experience in the medical device and diagnostic industry. Josh has played instrumental roles commercializing new technologies for companies such as NuVasive, Saint Francis Medical Technologies, Confluent Surgical, NeuroLogica, and Leica Microsystems. Most recently, he was Chief Commercial Officer for CareDx where he led sales and marketing efforts. He received a BA in Economics from University of California, Berkeley.
David has served as Auris’ CFO for more than three years and is responsible for all finance and administrative functions, including Accounting, People & Culture, IT and Facilities. David has 30 years of finance and operations management experience and is a veteran of the Silicon Valley’s entrepreneurial environment, serving in both life science and technology companies. He holds a Bachelor of Arts degree in Business Economics from the University of California at Santa Barbara. David enjoys hiking and photography.
Dan Bradford joined Auris in 2015 as Vice President of Operations, bringing more than 25 years of experience leading worldwide operations within the medical device industry. He has extensive expertise in the development and commercialization of complex, high-quality medical systems and bringing those products to the healthcare marketplace.
Dan earned a Bachelor’s Degree in Business Administration from San Diego State University.
Eric holds the position of Vice President of Sales and Marketing. He joined the company in Spring of 2016 and is leading the company’s commercialization efforts. Prior to Auris, Eric spent nine years at Intuitive Surgical in marketing with his last position as Vice President of Product Marketing. Eric began his medical device career at Stryker. When not working, Eric enjoys spending time with his wife and three children. Eric holds an MBA from the Stanford Graduate School of Business and a BA from Pomona College.
Richard Leparmentier joined Auris in early 2016 as the Vice President of Engineering where he leads the R&D team. Mr. Leparmentier brings over 20 years of experience in medical device and high-tech sectors in strategic planning and operations across global environments.
Richard holds an engineering degree in Biology and Micromechanics from Ecole Polytechnique in France, A Master from Telecom Paris and a MBA from NYU L. Stern School of Business. Richard cycles daily.
David joined Auris in 2012 to build and lead the engineering organization. He brings 20 years of R&D leadership experience, developing complex medical device technologies for companies including Intuitive Surgical, Neoguide, Optimedica and Topcon Medical Laser Systems. David holds an MS in EE from Rensselaer Polytechnic and Bachelor’s degrees in EE and CS from SUNY-Buffalo. When not at work, David enjoys furniture building, Crossfit, and hanging out with his wife and four children.
David joined Auris in 2014 following 15 years in healthcare management, investing and entrepreneurship. David is responsible for the Auris’ external relationships with technology partners, strategic partners and investments. He began his career analyzing the healthcare industry as a reporter and investment banker. In addition, David has served in numerous leadership roles at Kyphon, EndoGastric Solutions and Providence Medical Technologies. David is passionate about friends, family, food and baseball.
We are creating a new future.